Why the study?
COVID-19 susceptibility, mortality, and cardiovascular outcomes show significant sex differences driven by biological and behavioral factors, requiring discussion of the underlying mechanisms.
COVID-19 affects men and women differently, with men facing higher acute cardiovascular severity and mortality, while women are more prone to long-COVID syndrome.
Sex differences in COVID-19 cardiovascular outcomes warrant sex-stratified monitoring; leaves open optimal sex-specific interventions.
The coronavirus disease 19 (COVID-19), due to coronavirus 2 (SARS-CoV-2) infection, presents with an extremely heterogeneous spectrum of symptoms and signs. COVID-19 susceptibility and mortality show a significant sex imbalance, with men being more prone to infection and showing a higher rate of hospitalization and mortality than women. In particular, cardiovascular diseases (preexistent or arising upon infection) play a central role in COVID-19 outcomes, differently in men and women. This review will discuss the potential mechanisms accounting for sex/gender influence in vulnerability to COVID-19. Such variability can be ascribed to both sex-related biological factors and sex-related behavioural traits. Sex differences in cardiovascular disease and COVID-19 involve the endothelial dysfunction, the innate immune system and the renin-angiotensin system (RAS). Furthermore, the angiotensin-converting enzyme 2 (ACE2) is involved in disease pathogenesis in cardiovascular disease and COVID-19 and it shows hormone-dependent actions. The incidence of myocardial injury during COVID-19 is sex-dependent, predominantly in association with a greater degree of inflammation and coagulation disorders among men. Its pathogenesis is not fully elucidated, but the main theories foresee a direct role for the ACE2 receptor, the hyperimmune response and the RAS imbalance, which may also lead to isolated presentation of COVID-19-mediated myopericarditis. Moreover, the latest evidence on cardiovascular diseases and their relationship with COVID-19 during pregnancy will be discussed. Finally, authors will analyse the prevalence of the long-covid syndrome between the two sexes and its impact on the quality of life and cardiovascular health.
No takes yet. Share an insight, caveat, or question.
Moscucci et al. (2022) conducted a review in COVID-19 and cardiovascular disease. COVID-19 vs. Men was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: